News & Media
|Hemostemix Retains Stonegate Capital Partners for Investor Relations|
|May 11 2015 -
Hemostemix Inc. announced today that it has retained Stonegate Capital Partners, Inc. (“Stonegate”) to assist with strategic investor relations services in the U.S. institutional investment community. Stonegate provides a full range of services to help a select group of public company clients build awareness, manage investor expectations, and broaden and strengthen investor relationships with a strong focus on institutional investors.
“We are committed to expanding our investor relations efforts, and we have a compelling story to tell,” said Dr. Elmar Burchardt, president and CEO of Hemostemix. “Stonegate’s extensive institutional relationships and experience with complex capital market issues will help us communicate with current shareholders and prospective investors as we create long-term shareholder value.”
About Stonegate Capital Partners
Stonegate Capital Partners is a privately owned investment banking and corporate advisory firm that is based in Dallas, Texas, and dedicated to serving the specialized needs of public companies. For over 40 years, Stonegate has been bringing public companies and institutional investors together, either by virtue of private placements, coordinating block trades, or through open market transactions.
Since inception, Stonegate's mission has been to find innovative, undervalued public companies for its network of leading institutional investors who seek high quality investment opportunities. Its robust institutional outreach effort is the foundation of the firm, and a core aspect of its success. This, combined with their team's extensive institutional relationships and experience with complex capital market issues, creates an unparalleled platform for companies looking to grow their institutional shareholder base and ultimately realize optimal valuation in their stock. For further information, visit stonegateinc.com.
For more information, please contact email@example.com